AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,501,368 | -12.5% | 122,855 | -29.8% | 0.00% | 0.0% |
| Q2 2022 | $4,002,000 | +93.2% | 174,999 | +347.0% | 0.00% | +100.0% |
| Q1 2021 | $2,071,000 | -19.8% | 39,146 | -29.2% | 0.00% | -50.0% |
| Q4 2020 | $2,583,000 | -8.5% | 55,278 | -30.4% | 0.00% | 0.0% |
| Q3 2020 | $2,823,000 | +2333.6% | 79,384 | +3548.2% | 0.00% | – |
| Q2 2020 | $116,000 | +100.0% | 2,176 | +39.5% | 0.00% | – |
| Q1 2020 | $58,000 | -86.9% | 1,560 | -83.2% | 0.00% | – |
| Q4 2019 | $444,000 | -35.7% | 9,277 | -56.5% | 0.00% | -100.0% |
| Q3 2019 | $691,000 | +1254.9% | 21,315 | +1951.5% | 0.00% | – |
| Q2 2019 | $51,000 | -81.1% | 1,039 | -74.0% | 0.00% | – |
| Q1 2019 | $270,000 | +37.8% | 4,000 | -5.8% | 0.00% | – |
| Q4 2018 | $196,000 | -51.6% | 4,245 | -19.3% | 0.00% | – |
| Q3 2018 | $405,000 | -11.0% | 5,257 | -2.7% | 0.00% | – |
| Q2 2018 | $455,000 | +14.6% | 5,405 | +11.2% | 0.00% | – |
| Q1 2018 | $397,000 | +95.6% | 4,860 | +36.9% | 0.00% | – |
| Q4 2017 | $203,000 | +50.4% | 3,551 | +74.8% | 0.00% | – |
| Q3 2017 | $135,000 | +27.4% | 2,031 | -1.8% | 0.00% | – |
| Q2 2017 | $106,000 | -12.4% | 2,068 | 0.0% | 0.00% | – |
| Q1 2017 | $121,000 | +13.1% | 2,068 | +11.7% | 0.00% | – |
| Q4 2016 | $107,000 | -88.8% | 1,852 | -89.8% | 0.00% | -100.0% |
| Q3 2016 | $958,000 | +121.8% | 18,123 | +75.6% | 0.00% | – |
| Q2 2016 | $432,000 | +2060.0% | 10,323 | +1964.6% | 0.00% | – |
| Q1 2016 | $20,000 | -87.7% | 500 | -80.0% | 0.00% | – |
| Q4 2015 | $162,000 | +125.0% | 2,500 | +145.8% | 0.00% | – |
| Q3 2015 | $72,000 | -85.8% | 1,017 | -77.6% | 0.00% | -100.0% |
| Q2 2015 | $506,000 | +42.9% | 4,550 | +21.3% | 0.00% | – |
| Q1 2015 | $354,000 | -45.5% | 3,750 | -35.3% | 0.00% | -100.0% |
| Q4 2014 | $650,000 | +79.6% | 5,800 | -1.7% | 0.00% | – |
| Q3 2014 | $362,000 | +4425.0% | 5,900 | +3370.6% | 0.00% | – |
| Q2 2014 | $8,000 | -93.2% | 170 | -94.3% | 0.00% | – |
| Q1 2014 | $117,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |